Authors


Irina Pikuleva, PhD

Latest:

Irina Pikuleva, PhD: Activating CYP46A1 with Efavirenz

The Carl F. Asseff Professor of Ophthalmology and the Director of the Visual Sciences Research Center at Case Western Reserve University spoke about the beginnings of her work with efavirenz.


Lisa Belter, MPH

Latest:

Changes Needed to Improve SMA Costs: Lisa Belter, MPH

The director of research analytics at Cure SMA detailed the ways to decrease care management costs for patients with spinal muscular atrophy and the role incoming treatments can play.


Amy Perrin Ross, APN, MSN, CNRN, MSCN

Latest:

Concluding Thoughts on Biosimilars in Multiple Sclerosis

Amy Perrin Ross, APN, Patricia Melville, NP-C, Aliza Ben-Zacharia, PhD, DNP, ANP-BC, and John Kramer, PA-C share their advice for facilitating uptake of biosimilars in clinical practices.


Alissa Willis, MD

Latest:

The Brisk Evolution of Multiple Sclerosis Care

We are closer than ever to individualized management of MS, and keeping up with the rapidly changing pace of MS care is challenging even for an MS specialist.


Clyde E. Markowitz, MD

Latest:

New Horizons in Multiple Sclerosis

Experts share insights on the latest innovations in multiple sclerosis research, in highlights from a recent State of the Science SummitTM, presented by Neurology Live®.


Zachary Grinspan, MD, MS, Isaac Mayefsky

Latest:

Zachary Grinspan, MD, MS: Improving Adherence to Status Epilepticus Protocols

The director of the Pediatric Epilepsy Program is joined by an MD candidate from Weill Cornell Medicine to discuss the protocol used to treat patients with status epilepticus.


Pierrick Arnal, PhD

Latest:

Pierrick Arnal, PhD: Conducting Sleep Studies With the Dreem Headband

The vice president of science and medical at Dreem offered his opinion on how the company’s headband device can improve how sleep studies are conducted.


Andrew Blumenfeld, MD

Latest:

Potential Layered Migraine Treatment Approaches to Research: Andrew Blumenfeld, MD

The director of the Headache Center of Southern California discussed research opportunities for layered treatment approaches in migraine.


James Hendrix, PhD

Latest:

James Hendrix, PhD: Progress and Challenges in the Alzheimer Space

Hendrix spoke to the challenges he and colleagues come across, as well as his hope for the promising future.


Jill Jarecki, PhD

Latest:

Spinal Muscular Atrophy and COVID-19: Guidance and Resources for Providers

Advocacy organization Cure SMA provides guidance for health care providers caring for patients with SMA during the ongoing COVID-19 pandemic.


Rohit Dhall, MD, MSPH

Latest:

Noninvasive Neuromodulation for Essential Tremor: An Important Tool for Maintaining Independence at Home

Noninvasive neuromodulation with TAPS is a safe and effective tool that offers particular utility in the age of COVID-19 when other treatment options may be less accessible.


Staff Writer

Latest:

Gene Therapy Shows Robust Activity for Duchenne Muscular Dystrophy

A novel gene therapy has demonstrated impressive early results in a small sample of 3 children with Duchenne muscular dystrophy.


Jeffrey Ratliff, MD

Latest:

An Emerging Framework for Parkinson Disease Therapeutics

The diagnosis of Parkinson disease may seem straightforward at first, requiring neurologists to rely on their eyes and hands, but the treatment process can present challenges for both physicians and patients.


Andrew Russman, DO

Latest:

Understanding the Evolving Care of Rehabilitation and Stroke Recovery

Explore innovative neurorehabilitation strategies for stroke recovery, emphasizing personalized approaches and advanced technologies to enhance patient outcomes.


Peter Nakaji, MD

Latest:

Peter Nakaji, MD: The State of Science for Epilepsy Surgery

The chair of the Department of Neurosurgery at Banner-University Medical Center discusses the current state of the science being done in the realm of epilepsy surgery.



Katrina Celis, MD

Latest:

Katrina Celis, MD: Genetics and Their Role in Alzheimer Research, Clinical Care

The postdoctoral fellow at the University of Miami Miller School of Medicine detailed the role that increased APOE ε4 expression can have on future research and clinical care.



Naeem Khan, MD

Latest:

Naeem Khan, MD: Ticagrelor Shines in Phase 3 THALES Trial

The vice president of AstraZeneca’s Cardiovascular and Metabolic Diseases Portfolio detailed the results from the phase 3 THALES trial, and where ticagrelor stands among other FDA approved stroke treatments.


Marwan Sabbagh, MD

Latest:

The Future Outlook for Alzheimer’s Disease

Sharon Cohen, MD, and Marwan Sabbagh, MD, share their final thoughts on Alzheimer's disease and offer advice on strategies to reduce the risk of developing AD and slow the progression of the disease for those already affected.


Kathleen Hawker, MD

Latest:

Kathleen Hawker, MD: Clinical Findings for Satralizumab in Treating NMOSD

The group medical director of neuroscience at Genentech spoke to the findings recently presented at the 6th Annual Meeting of the European Academy of Neurology.


Stuart H. Isaacson, MD, FAAN

Latest:

Clinical Nurse Educators, Dosing Titrations to Manage Parkinson Disease

Panelists discuss how clinical nurse educators serve as vital partners in continuous subcutaneous apomorphine infusion management, providing patient education, troubleshooting technical issues, and collaborating with physicians on dosing titrations to optimize Parkinson disease symptom control.



Dawn Buse, PhD

Latest:

Dawn Buse, PhD: Inappropriate Prescriptions in Acute, Preventive Migraine Treatment

The clinical professor of neurology at Albert Einstein College of Medicine spoke to the findings of the OVERCOME study, and how recent literature has suggested that improper prescriptions and medication use in migraine have been ongoing in spite of the current recommendations.


Amy Sullivan, PsyD

Latest:

Amy Sullivan, PsyD: Personalized Approach to Fatigue in Multiple Sclerosis

The Director of Behavioral Medicine at the Mellen Center for MS Treatment and Research at the Cleveland Clinic spoke about how she approaches fatigue in MS from a behavioral standpoint.


Jeff Waugh, MD, PhD

Latest:

Jeff Waugh, MD, PhD: Viewing Striatal Injury More Granularly

Despite some mistrusting the abilities of imaging to aid in therapeutic development, a new MRI method could better inform the anatomical understanding of the striatum.


Patricia K. Coyle, MD

Latest:

The Role of High-Efficacy Therapies in Multiple Sclerosis Treatment: Patricia K. Coyle, MD

At the 2025 ACTRIMS Forum, the director of the MS Comprehensive Care Center at Stony Brook Medicine discussed the evolution of high-efficacy treatments for MS. [WATCH TIME: 4 minutes]



Dominic Pelle, MD

Latest:

Dominic Pelle, MD: Improving Patient-Reported Outcomes in Spine Surgery

The spine surgeon in the Center for Spine Health at Cleveland Clinic spoke to the importance of improving patient-reported outcomes and ensuring consistent communication with patients undergoing spine surgery.


© 2025 MJH Life Sciences

All rights reserved.